| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 44 |
| 1 | TADALAFIL | 14 |
| 2 | MACITENTAN | 13 |
| 3 | OCTREOTIDE ACETATE | 11 |
| 4 | SILDENAFIL CITRATE | 11 |
| 5 | SILDENAFIL | 10 |
| 6 | SODIUM CHLORIDE | 10 |
| 7 | SODIUM CHLORIDE TABLET | 10 |
| 8 | SODIUM CHLORIDE TABLETS | 10 |
| 9 | AMBRISENTAN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 1 | KETAMINE HYDROCHLORIDE | 5 | 0.0010 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 4 | TELMISARTAN | 8 | 0.0004 |
| 5 | KETOPROFEN | 5 | 0.0004 |
| 6 | OCTREOTIDE ACETATE | 11 | 0.0004 |
| 7 | TREPROSTINIL | 44 | 0.0003 |
| 8 | BACLOFEN INJECTION | 1 | 0.0003 |
| 9 | MIDODRINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 46 |
| 1 | Endothelin Receptor Antagonist [EPC] | 22 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 20 |
| 3 | Osmotic Laxative [EPC] | 11 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 8 |
| 6 | Loop Diuretic [EPC] | 8 |
| 7 | Opioid Agonist [EPC] | 8 |
| 8 | Aldosterone Antagonist [EPC] | 6 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 46 | 0.0003 |
| 1 | Barbiturate [EPC] | 2 | 0.0002 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 20 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |
| 5 | Endothelin Receptor Antagonist [EPC] | 22 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 5 | 0.0001 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 9 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |